Notice of Results

RNS Number : 1997Q

Syncona Limited

26 October 2021

 

Syncona Limited

Notice of Interim Results

26 October 2021

Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, will announce its interim results for the six months ended 30 September 2021 on Thursday 11 November 2021.

Syncona will host a webcast and conference call the same day at 9.00am GMT, with an opportunity to ask questions via the conference call line. The webcast will be available on the Company's website at https://www.synconaltd.com/ or via this link . Alternatively, please contact [e-mail] for details of the conference call.

[ENDS]

Enquiries

Syncona Ltd

Annabel Clay 

Tel: [phone]

FTI Consulting

Ben Atwell / Natalie Garland-Collins / Tim Stamper

Tel: [phone]

About Syncona

Syncona's purpose is to invest to extend and enhance human life. We do this by founding and building companies to deliver transformational treatments to patients in areas of high unmet need.

Our strategy is to found, build and fund companies around exceptional science to create a dynamic portfolio of 15-20 globally leading healthcare businesses for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or few treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.

 

END

 

 

NORDKPBQFBDDCKB